课题基金 / 基金详情

UPGRADE OF FACS-IV FLOW CYTOMETRY SYSTEM

UPGRADE OF FACS-IV FLOW CYTOMETRY SYSTEM
FACS-IV流式细胞术系统升级
批准号:
3519234
负责人:
FRITZ H BACH
金额:
$10.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1986-05-31

项目摘要

项目成果

FRITZ H BACH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this proposal is to acquire compatible equipment to upgrate an existing flow cytometry and cell sorting facility. The major users of this facility apply flow cytometry and cell sorting to a number of basic research areas, including: cloning of different functional subtypes of human T lymphocytes with anti-tumor and anti-HLA activity; mechanisms of alopecia; differentiation of bone marrow cells; effects of estrogens on breast cancers; depressed immune function in agen; mechanism of rheumatoid arthritis; and effects of immunotoxins on human lymphoid cells. Need for improved instrumentations arises from a number of research aims which can be approached with difficulty, if at all, with the existing equipment. The new equipment requested will be added to the existing FACS-IV flow cytometer and cell sorter. 1) Second argon ion laser and tunable dye head with third fluorescence detection channel. These items will allow three-color immunofluorescence, dual fluorochrome analysis witih forward and 90 degree light scatter, and studies on viable cells requiring cell cycle analysis and immuno-fluorescence. 2) Consort 40C and graphics plotter. The Consort 40C is a high speed, user accessible computer supplied with software to allow acquisition and analysis of multiparameter, list mode data. Without this computer the full capabilities of the existing and requested equipment will not be realized. The graphics plotter is needed to provide legible hard copy output of information processed by the Consort 40C.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heme Oxygenase-1: protection against chronic rejection
Heme Oxygenase-1: protection against chronic rejection
Heme Oxygenase-1: protection against chronic rejection
Heme Oxygenase-1: protection against chronic rejection
海外基金